It’s Official: FDA Panel Will Review Tysabri On March 7th (ELN, BIIB)

|
Includes: BIIB, ELN
by: BioBlogger

Elan (ticker: ELN) and Biogen Idec (ticker: BIIB) announced today that an FDA panel will convene on March 7th to discuss the fate of Tysabri. Information on the panel can be viewed here.

Comment: More on Tysabri here.